|
|
Volumn , Issue , 2013, Pages
|
|
Nonhormone therapy for metastatic castration-resistant prostate cancer: chemotherapy, bone-targeted treatments, and others
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
ANIMAL;
BONE NEOPLASMS;
DRUG DESIGN;
DRUG EFFECTS;
HUMAN;
MALE;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SECONDARY;
SIGNAL TRANSDUCTION;
TIME;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL MARKERS;
BONE NEOPLASMS;
DRUG DESIGN;
HUMANS;
MALE;
MOLECULAR TARGETED THERAPY;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SIGNAL TRANSDUCTION;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84946218589
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e161 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|